Skip to content

Treatment of Acne Vulgaris in Topical Kalonji with Sirka

Therapeutic evaluation of topical Kalonji (Nigella sativa) with Sirka (vinegar) in Buthūr-i Labaniyya (acne vulgaris) - a randomised control trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/05/042368
Enrollment
40
Registered
2022-05-04
Start date
Unknown
Completion date
Unknown
Last updated
2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L700- Acne vulgaris

Interventions

Intervention1: Kalonji (Nigella sativa) with Sirka (vinegar): Form Freshly prepared Tila (liniment) by mixing Kalonji (Nigella sativa) powder with Sirka (vinegar) Mode of application Topical Dosage Qu

Sponsors

Luqman Unani Medical College Hospital and Research Center
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of age group of 13 to 40 years irrespective of gender place and education. Patients having the following symptoms of Busūr Labaniyya Comedones Papules Pustules Nodules Itching Erythema Clinically diagnosed cases of acne vulgaris without associated disorders

Exclusion criteria

Exclusion criteria: • Patient aged less than 13 years or more than 40 years • Patient with other associated disorders like acne rosacea, acne fulminans, acne necrotica, psoriasis, eczema etc. • Mentally retarded person • Patient on corticosteroid therapy, Anticonvulsant therapy, or taking oral contraceptive pills for last 1 month. • Pregnant and lactating women. • Patients suffering with other severe systemic illness.

Design outcomes

Primary

MeasureTime frame
Global Acne Grading System (GAGS) Cookâ??s Acne Grading Scale (using photographic standards)Timepoint: Baseline 14th day 28th day

Secondary

MeasureTime frame
Quality of Life by Cardiff Acne Disability Index (CADI)Timepoint: At the end of Treatment

Countries

India

Contacts

Public ContactDr Meenu Doni

Luqman Unani Medical College Hospital and Research Centre

mdiliyasp@gmail.com9482854786

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026